MERCK SHARP DOHME PHARMA TBK PT

Business Nature: Manufacturer

Corporate Profile:

PT Merck Sharp Dohme Pharma Tbk is a prominent pharmaceutical company operating in Indonesia. It functions primarily as a manufacturing entity, specializing in the production of a wide range of pharmaceutical products. As a subsidiary of the global healthcare leader Merck & Co., Inc. (known as MSD outside the United States and Canada), the company is dedicated to developing and manufacturing high-quality medicines and vaccines to address critical health challenges. The company operates advanced production facilities that adhere to international quality standards and Good Manufacturing Practices (GMP) to ensure the safety and efficacy of its pharmaceutical output for both domestic and international markets.

PT Merck Sharp Dohme Pharma Tbk manufactures and distributes a wide range of pharmaceutical products. Below are the key categories and examples of their offerings:

Vaccines

Gardasil (Human Papillomavirus Vaccine)

RotaTeq (Rotavirus Vaccine)

Pneumovax 23 (Pneumococcal Vaccine)

M-M-R II (Measles, Mumps, and Rubella Vaccine)

Oncology and Hematology

Keytruda (Pembrolizumab)

Lynparza (Olaparib)

Anti-Infectives

Invanz (Ertapenem)

Cancidas (Caspofungin)

Cardiovascular and Metabolic

Zetia (Ezetimibe)

Januvia (Sitagliptin)

Janumet (Sitagliptin and Metformin)

Women’s Health and Fertility

Puregon (Follitropin beta)

Orgalutran (Ganirelix)

General Medicine

Singulair (Montelukast)

Arcoxia (Etoricoxib)

Please note that product availability and portfolio updates may change according to local regulatory approvals and commercial strategies in Indonesia.